CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 46 filers reported holding CATALYST BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $314,000 | -24.5% | 476,625 | +4.9% | 0.04% | -33.9% |
| Q4 2021 | $416,000 | -77.7% | 454,346 | 0.0% | 0.06% | -52.7% |
| Q3 2021 | $1,867,000 | -25.9% | 454,346 | -21.8% | 0.13% | -35.8% |
| Q2 2021 | $2,518,000 | -14.0% | 581,200 | 0.0% | 0.20% | +106.1% |
| Q1 2021 | $2,929,000 | – | 581,200 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 66,951 | $13,859 | 0.01% |
| Colorado Capital Management, Inc. | 34,165 | $7 | 0.01% |
| Nantahala Capital Management | 160,430 | $33,209 | 0.00% |
| Kynam Capital Management, LP | 89,886 | $18,606 | 0.00% |
| Keebeck Wealth Management, LLC | 20,000 | $4,140 | 0.00% |
| MORGAN STANLEY | 38,404 | $7,950 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 259,467 | $52 | 0.00% |
| BlackRock Inc. | 169,904 | $35,170 | 0.00% |
| Bank of New York Mellon Corp | 200,638 | $41,532 | 0.00% |
| Citadel Advisors | 5,700 | $1,180 | 0.00% |